Tapewire

Nasdaq · USD

ARDX

ARDELYX, INC.

Export transactions ↓
Tapewire entity
4972
SEC CIK
0001437402
Parsed reports
540

Last 12 months

Inside the activity.

1 purchase rows · 78 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 202500
Jan 202601
Feb 2026125
Mar 202601
Apr 202601
May 2026020
Jun 202602
Jul 202601
Aug 2026021
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 20, 2026 Filed Feb 24, 2026 01:45 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 5,576 $5.71 $31,860.15
Disclosure

SEC source: 0001610717-26-000058 · form4.xml · nonDerivative · entry 2

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,856,991

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
February 20, 2026 Filed Feb 24, 2026 01:45 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 40,401 $5.87 $236,951.87
Disclosure

SEC source: 0001610717-26-000058 · form4.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,862,567

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
January 23, 2026 Filed Jan 26, 2026 21:27 UTC
Foster Eric DuaneChief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 206,915 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0001610717-26-000023 · form4.xml · derivative · entry 2

Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206,915

Underlying: Common Stock · 206,915 shares

Expires 2036-01-23

F3 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 23, 2026 Filed Jan 26, 2026 21:27 UTC
Foster Eric DuaneChief Commercial Officer
GrantCommon Stock 137,945 $0.00 $0.00
Disclosure

SEC source: 0001610717-26-000023 · form4.xml · nonDerivative · entry 1

Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 436,409

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

F2 · balance_after: Includes the purchase of 2,780 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2025.

Read SEC document
January 23, 2026 Filed Jan 26, 2026 21:23 UTC
Williams Laura AChief Patient Officer
GrantStock Option (Right to Buy) · Derivative 124,040 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0001610717-26-000020 · form4.xml · derivative · entry 2

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,040

Underlying: Common Stock · 124,040 shares

Expires 2036-01-23

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 23, 2026 Filed Jan 26, 2026 21:23 UTC
Williams Laura AChief Patient Officer
GrantCommon Stock 82,695 $0.00 $0.00
Disclosure

SEC source: 0001610717-26-000020 · form4.xml · nonDerivative · entry 1

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 444,258

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
January 23, 2026 Filed Jan 26, 2026 21:29 UTC
Kelliher MikeSee Remarks
GrantStock Option (Right to Buy) · Derivative 154,625 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0001610717-26-000025 · form4.xml · derivative · entry 2

Kelliher Mike · CIK 0001987188 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,625

Underlying: Common Stock · 154,625 shares

Expires 2036-01-23

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 23, 2026 Filed Jan 26, 2026 21:29 UTC
Kelliher MikeSee Remarks
GrantCommon Stock 103,080 $0.00 $0.00
Disclosure

SEC source: 0001610717-26-000025 · form4.xml · nonDerivative · entry 1

Kelliher Mike · CIK 0001987188 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 374,261

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
January 23, 2026 Filed Jan 26, 2026 21:27 UTC
Hohenleitner SusanChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 128,505 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0001610717-26-000024 · form4.xml · derivative · entry 2

Hohenleitner Susan · CIK 0002093095 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,505

Underlying: Common Stock · 128,505 shares

Expires 2036-01-23

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 23, 2026 Filed Jan 26, 2026 21:27 UTC
Hohenleitner SusanChief Financial Officer
GrantCommon Stock 85,670 $0.00 $0.00
Disclosure

SEC source: 0001610717-26-000024 · form4.xml · nonDerivative · entry 1

Hohenleitner Susan · CIK 0002093095 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 232,566

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
January 23, 2026 Filed Jan 26, 2026 21:26 UTC
RAAB MICHAELDirector · President & CEO
GrantStock Option (Right to Buy) · Derivative 669,330 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0001610717-26-000022 · form4.xml · derivative · entry 4

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 669,330

Underlying: Common Stock · 669,330 shares

Expires 2036-01-23

F5 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 23, 2026 Filed Jan 26, 2026 21:26 UTC
RAAB MICHAELDirector · President & CEO
GrantCommon Stock 446,220 $0.00 $0.00
Disclosure

SEC source: 0001610717-26-000022 · form4.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,902,968

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

F2 · balance_after: Includes the purchase of 1,385 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2025.

Read SEC document
January 23, 2026 Filed Jan 26, 2026 21:25 UTC
Brady James ParkerChief Human Resources Officer
GrantStock Option (Right to Buy) · Derivative 149,185 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0001610717-26-000021 · form4.xml · derivative · entry 2

Brady James Parker · CIK 0002088887 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,185

Underlying: Common Stock · 149,185 shares

Expires 2036-01-23

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 23, 2026 Filed Jan 26, 2026 21:25 UTC
Brady James ParkerChief Human Resources Officer
GrantCommon Stock 99,455 $0.00 $0.00
Disclosure

SEC source: 0001610717-26-000021 · form4.xml · nonDerivative · entry 1

Brady James Parker · CIK 0002088887 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,455

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
January 23, 2026 Filed Jan 26, 2026 21:22 UTC
Bishop John ESee Remarks
GrantStock Option (Right to Buy) · Derivative 186,500 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0001610717-26-000019 · form4.xml · derivative · entry 2

Bishop John E · CIK 0001308911 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,500

Underlying: Common Stock · 186,500 shares

Expires 2036-01-23

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 23, 2026 Filed Jan 26, 2026 21:22 UTC
Bishop John ESee Remarks
GrantCommon Stock 124,330 $0.00 $0.00
Disclosure

SEC source: 0001610717-26-000019 · form4.xml · nonDerivative · entry 1

Bishop John E · CIK 0001308911 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 342,330

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
January 23, 2026 Filed Jan 27, 2026 21:13 UTC GrantStock Option (Right to Buy) · Derivative 69,360 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0001610717-26-000028 · form4.xml · derivative · entry 2

Reilly Joseph James · CIK 0002044416 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,360

Underlying: Common Stock · 69,360 shares

Expires 2036-01-23

F3 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 23, 2026 Filed Jan 27, 2026 21:13 UTC GrantCommon Stock 46,200 $0.00 $0.00
Disclosure

SEC source: 0001610717-26-000028 · form4.xml · nonDerivative · entry 1

Reilly Joseph James · CIK 0002044416 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,781

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

F2 · balance_after: Includes the purchase of 1,667 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2025.

Read SEC document
January 08, 2026 Filed Jan 9, 2026 23:59 UTC
Williams Laura AChief Patient Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 0 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001869194-26-000002 · wk-form4_1768003182.xml · derivative · entry 3

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,000

Underlying: Common Stock · 50,000 shares

Expires 2032-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 08, 2026 Filed Jan 9, 2026 23:59 UTC
Williams Laura AChief Patient Officer
SaleCommon Stock 50,000 $6.98 $348,900.00
Disclosure

SEC source: 0001869194-26-000002 · wk-form4_1768003182.xml · nonDerivative · entry 2

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 361,563

F1 · price: This transaction was executed in multiple trades in prices ranging from $6.97 to $7.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,667 shares under the Ardelyx Employee Stock Purchase Plan in August 2025.

Read SEC document
January 08, 2026 Filed Jan 9, 2026 23:59 UTC
Williams Laura AChief Patient Officer
Exercise / conversionCommon Stock 50,000 $0.99 $49,500.00
Disclosure

SEC source: 0001869194-26-000002 · wk-form4_1768003182.xml · nonDerivative · entry 1

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 409,896

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 21, 2025 Filed Nov 25, 2025 21:21 UTC SaleCommon Stock 11,086 $5.54 $61,382.07
Disclosure

SEC source: 0001610717-25-000387 · form4.xml · nonDerivative · entry 1

Reilly Joseph James · CIK 0002044416 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,914

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
November 21, 2025 Filed Nov 25, 2025 21:22 UTC
Foster Eric DuaneChief Commercial Officer
SaleCommon Stock 5,814 $5.54 $32,191.54
Disclosure

SEC source: 0001610717-25-000388 · form4.xml · nonDerivative · entry 1

Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 295,684

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
November 21, 2025 Filed Nov 25, 2025 21:35 UTC
Williams Laura AChief Patient Officer
SaleCommon Stock 6,426 $5.54 $35,580.12
Disclosure

SEC source: 0001610717-25-000394 · form4.xml · nonDerivative · entry 1

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 359,896

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
November 21, 2025 Filed Nov 25, 2025 21:44 UTC SaleCommon Stock 5,995 $5.54 $33,193.72
Disclosure

SEC source: 0001610717-25-000397 · form4.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 299,895

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
November 21, 2025 Filed Nov 25, 2025 21:42 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 46,887 $5.54 $259,608.63
Disclosure

SEC source: 0001610717-25-000396 · form4.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,455,363

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
November 21, 2025 Filed Nov 25, 2025 21:38 UTC
Kelliher MikeSee Remarks
SaleCommon Stock 5,560 $5.54 $30,785.16
Disclosure

SEC source: 0001610717-25-000395 · form4.xml · nonDerivative · entry 1

Kelliher Mike · CIK 0001987188 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 271,181

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 26, 2025 Filed Aug 28, 2025 23:30 UTC
Williams Laura AChief Patient Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001628280-25-041339 · wk-form4_1756423821.xml · derivative · entry 4

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 50,000 shares

Expires 2032-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
August 26, 2025 Filed Aug 28, 2025 23:30 UTC
Williams Laura AChief Patient Officer
SaleCommon Stock 30,000 $6.12 $183,630.00
Disclosure

SEC source: 0001628280-25-041339 · wk-form4_1756423821.xml · nonDerivative · entry 3

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 366,322

F1 · price: This transaction was executed in multiple trades in prices ranging from $6.04 to $6.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 26, 2025 Filed Aug 28, 2025 23:30 UTC
Williams Laura AChief Patient Officer
SaleCommon Stock 50,000 $6.12 $306,050.00
Disclosure

SEC source: 0001628280-25-041339 · wk-form4_1756423821.xml · nonDerivative · entry 2

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 396,322

F1 · price: This transaction was executed in multiple trades in prices ranging from $6.04 to $6.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
August 26, 2025 Filed Aug 28, 2025 23:30 UTC
Williams Laura AChief Patient Officer
Exercise / conversionCommon Stock 50,000 $0.99 $49,500.00
Disclosure

SEC source: 0001628280-25-041339 · wk-form4_1756423821.xml · nonDerivative · entry 1

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 446,322

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 21, 2025 Filed Aug 26, 2025 01:02 UTC
Foster Eric DuaneChief Commercial Officer
SaleCommon Stock 15,308 $5.93 $90,802.46
Disclosure

SEC source: 0001628280-25-041130 · wk-form4_1756170140.xml · nonDerivative · entry 1

Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 301,498

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 21, 2025 Filed Aug 26, 2025 01:13 UTC
Williams Laura AChief Patient Officer
SaleCommon Stock 6,261 $5.93 $37,138.37
Disclosure

SEC source: 0001628280-25-041139 · wk-form4_1756170821.xml · nonDerivative · entry 1

Williams Laura A · CIK 0001869194 · Chief Patient Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 396,322

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 21, 2025 Filed Aug 25, 2025 21:12 UTC
Renz Justin AChief Financial Officer
SaleCommon Stock 7,037 $5.93 $41,741.37
Disclosure

SEC source: 0001628280-25-041137 · wk-form4_1756170732.xml · nonDerivative · entry 1

Renz Justin A · CIK 0001466562 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 409,052

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 21, 2025 Filed Aug 26, 2025 01:08 UTC
RAAB MICHAELDirector · President & CEO
SaleCommon Stock 45,687 $5.93 $271,001.58
Disclosure

SEC source: 0001628280-25-041135 · wk-form4_1756170491.xml · nonDerivative · entry 1

RAAB MICHAEL · CIK 0001321402 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,502,250

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 21, 2025 Filed Aug 26, 2025 01:03 UTC SaleCommon Stock 5,841 $5.93 $34,647.06
Disclosure

SEC source: 0001628280-25-041131 · wk-form4_1756170178.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 305,890

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 21, 2025 Filed Aug 28, 2025 23:29 UTC
Kelliher MikeChief Business Officer
SaleCommon Stock 5,417 $5.93 $32,132.02
Disclosure

SEC source: 0001628280-25-041338 · wk-form4_1756423788.xml · nonDerivative · entry 1

Kelliher Mike · CIK 0001987188 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 276,741

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
June 18, 2025 Filed Jun 24, 2025 00:40 UTC GrantStock Option (Right to Buy) · Derivative 54,059 $0.00 Strike: $3.61 $0.00
Disclosure

SEC source: 0001628280-25-032726 · wk-form4_1750725593.xml · derivative · entry 2

Cadoret-Manier Onaiza · CIK 0001799355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,059

Underlying: Common Stock · 54,059 shares

Expires 2035-06-18

F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.

F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
June 18, 2025 Filed Jun 24, 2025 00:40 UTC GrantCommon Stock 41,551 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-032726 · wk-form4_1750725593.xml · nonDerivative · entry 1

Cadoret-Manier Onaiza · CIK 0001799355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,701

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program.

Read SEC document
June 18, 2025 Filed Jun 24, 2025 00:44 UTC GrantStock Option (Right to Buy) · Derivative 54,059 $0.00 Strike: $3.61 $0.00
Disclosure

SEC source: 0001628280-25-032730 · wk-form4_1750725839.xml · derivative · entry 2

Bazemore Robert B · CIK 0001620152 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,059

Underlying: Common Stock · 54,059 shares

Expires 2035-06-18

F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.

F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
June 18, 2025 Filed Jun 24, 2025 00:44 UTC GrantCommon Stock 41,551 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-032730 · wk-form4_1750725839.xml · nonDerivative · entry 1

Bazemore Robert B · CIK 0001620152 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,551

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program.

Read SEC document
June 18, 2025 Filed Jun 24, 2025 00:42 UTC GrantStock Option (Right to Buy) · Derivative 54,059 $0.00 Strike: $3.61 $0.00
Disclosure

SEC source: 0001628280-25-032729 · wk-form4_1750725716.xml · derivative · entry 3

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,059

Underlying: Common Stock · 54,059 shares

Expires 2035-06-18

F3 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.

F4 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
June 18, 2025 Filed Jun 24, 2025 00:42 UTC GrantCommon Stock 41,551 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-032729 · wk-form4_1750725716.xml · nonDerivative · entry 2

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 413,543

F2 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program.

Read SEC document
June 18, 2025 Filed Jun 24, 2025 00:42 UTC GrantCommon Stock 21,468 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-032729 · wk-form4_1750725716.xml · nonDerivative · entry 1

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 371,992

F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program.

Read SEC document
June 18, 2025 Filed Jun 24, 2025 00:41 UTC GrantCommon Stock 15,235 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-032728 · wk-form4_1750725671.xml · nonDerivative · entry 1

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,291

F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program.

Read SEC document
June 18, 2025 Filed Jun 24, 2025 00:40 UTC
MOTT DAVID MDirector
GrantStock Option (Right to Buy) · Derivative 54,059 $0.00 Strike: $3.61 $0.00
Disclosure

SEC source: 0001628280-25-032727 · wk-form4_1750725635.xml · derivative · entry 3

MOTT DAVID M · CIK 0001219871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,059

Underlying: Common Stock · 54,059 shares

Expires 2035-06-18

F4 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.

F5 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
June 18, 2025 Filed Jun 24, 2025 00:40 UTC
MOTT DAVID MDirector
GrantCommon Stock 41,551 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-032727 · wk-form4_1750725635.xml · nonDerivative · entry 2

MOTT DAVID M · CIK 0001219871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,969,585

F3 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program.

F2 · balance_after: The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein.

Read SEC document
June 18, 2025 Filed Jun 24, 2025 00:40 UTC
MOTT DAVID MDirector
GrantCommon Stock 31,163 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-032727 · wk-form4_1750725635.xml · nonDerivative · entry 1

MOTT DAVID M · CIK 0001219871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,928,034

F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program.

F2 · balance_after: The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein.

Read SEC document
June 18, 2025 Filed Jun 24, 2025 00:39 UTC
Bhanji MunaDirector
GrantStock Option (Right to Buy) · Derivative 54,059 $0.00 Strike: $3.61 $0.00
Disclosure

SEC source: 0001628280-25-032725 · wk-form4_1750725535.xml · derivative · entry 2

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,059

Underlying: Common Stock · 54,059 shares

Expires 2035-06-18

F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.

F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.

Read SEC document
June 18, 2025 Filed Jun 24, 2025 00:39 UTC
Bhanji MunaDirector
GrantCommon Stock 41,551 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-032725 · wk-form4_1750725535.xml · nonDerivative · entry 1

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,353

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.